Lisa J. Herrinton, PhD

Lisa Herrinton, PhD, is a Research Scientist at the Division of Research, Kaiser Permanente, Northern California. She is an Associate Editor with the American Journal of Epidemiology and a Lecturer with the Department of Health Research and Policy, Stanford University School of Medicine. Dr. Herrinton received her doctoral training at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington, and her Master's training at Harvard University. Before her training in epidemiology, she was an environmental health scientist, consulting on health risk assessment to industry and government. She also served as a high school science and math teacher through the Peace Corps in Swaziland, Africa.

Dr. Herrinton directs a program in inflammatory bowel disease that is focused on epidemiology, quality of care, and outcomes. She also serves as site Principal Investigator on several research consortia organized under the HMO Research Network, including the Cancer Research Network and the Centers for Education and Research in Therapeutics. She leads and participates in numerous collaborative projects concerned primarily with health care effectiveness, as well as patient-reported quality of life. Her studies have involved data collection through linkage, medical record review, patient survey, provider survey, and qualitative approaches such as guided interviewing and focus groups. In addition, she provides service to her colleagues through work on planning and review committees.

Besides her work, Dr. Herrinton also enjoys her family and friends, books and hiking.

Current Positions:

	Research Scientist, Division of Research, Kaiser Permanente, Northern California
	Associate Editor, American Journal of Epidemiology
	Lecturer, Department of Health Research and Policy, Stanford University School of Medicine

Primary Research Interests:

	Inflammatory Bowel Disease
	Cancer
	Etiology Factors
	Quality of Care Outcomes
	Epidemiology Methods

Research Projects:

	Practice variation in maintenance of remission for IBD
	Health-related quality of life among colorectal cancer survivors with ostomy
	Epidemiology of marginal zone lymphoma
	A nested case-control study of NHL, serum levels of organochlorines and Epstein-Barr verus serology
	Cancer Research Network (CRN2)
	Centers for Education and Research in Therapeutics (CERT)
	Cancer Care Outcomes Research and Surveillance (CanCORS)

Completed Research Projects (partial listing):

	Population-based study of IBD incidence and prevalence
	Natural history of ulcerative colitis following initial hospitalization
	Cohort study of risk of lymphoproliferative cancer among rheumatoid arthritis patients
	Estimating the prevalence of IBD among ten geographically diverse managed care organizations
	Outcomes of prophylactic mastectomy
	Efficacy of prophylactic mastectomy
	Geographic variation in breast cancer incidence in Northern California
	End-of-life issues in ovarian cancer
	Relationship of serum endostatin with risk of cancer
	Efficacy of mammographic screening for breast cancer
	Cohort study of medical devices
	Preventative Oncology Academic Award in breast and testicular cancer etiology

Selected Publications:

	Herrinton LJ, Saftlas AF, Stanford JL, Brinton LA, Wolfe JN. Do alcohol intake and mammographic densities interact on the risk of breast cancer? Cancer 1993:71;3029-35.
	Herrinton LJ, Weiss NS. The incidence of Waldenstrom's macroglobulinemia. Blood 1993:82.
	Herrinton LJ, Stanford JL, Schwartz S, Weiss NS. Ovarian cancer in Asian migrants to the U.S. and their descendants. J Natl Cancer Inst 1994;86:1336-9.
	Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control 1994;5:479-83.
	Stanford JL, Herrinton LJ, Schwartz S, Weiss NS. Breast cancer incidence in Asian migrants to the U.S. and their descendants. Epidemiol 1995;6:181-3.
	Herrinton LJ, Friedman GD. Serum cholesterol concentration and risk of brain cancer. BMJ 1995;310:367-8.
	Herrinton LJ, Friedman GD, Baer D, Selby JV. Transferrin saturation and subsequent risk of cancer. Am J Epidemiol 1995;142:692-8.
	Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol 1995;142:961-4.
	Herrinton LJ, Weiss NS, Olshan AF. Multiple myeloma. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Second edition. New York: Oxford University Press, 1996.
	Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 1998;7:25-8.
	Herrinton LJ. Epidemiology of the revised European-American lymphoma (REAL) classification subtypes. Epidemio Rev 1998;20:187-203.
	Husson G, Herrinton L. How accurately does the medical record capture maternal history of cancer? Cancer Epidemiol Biomarkers Prev 2000;9:765-8.
	Herrinton LJ, Husson G. Relationship of childhood height and later risk of breast cancer. Am J Epidemiol 2001;154:618-23.
	McGuire V, Herrinton L, Whittemore AS. Race, epithelial ovarian cancer survival and membership in a large health maintenance organization. Epidemiology 2002;13(2):231-4.
	Herrinton LJ, Zhao W, Husson G. Management of cryptorchism and risk of testicular cancer. Am J Epidemiol 2003 Apr 1;157(7):602-5
	Elmore JG, Reisch LM, Barton MB, Barlow WE, Rolnick S, Harris EL, Herrinton LJ, Geiger AM, Beverly RK, Hart G, Yu O, Greene SM, Weiss NS, Fletcher SW. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005;97:1035-43.
	Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23:4275-86.
	Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med. 2005;165:516-20.
	Rolnick SJ, Hart G, Barton MB, Herrinton L, Flores SK, Paulsen KJ, Husson G, Harris EL, Geiger AM, Elmore JG, Fletcher SW. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data. Am J Manag Care. 2004;10:257-62.
	Field TS, Cernieux J, Buist D, Geiger A, Lamerato L, Hart G, Bachman D, Krajenta R, Greene S, Hornbrook MC, Ansell G, Herrinton L, Reed G. Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. J Natl Cancer Inst. 2004;96:148-52.
	Barton MB, West CN, Liu IL, Harris EL, Rolnick SJ, Elmore JG, Herrinton LJ, Greene SM, Nekhlyudov L, Fletcher SW, Geiger AM. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005;(35):61-6.
	Fenton JJ, Barton MB, Geiger AM, Herrinton LJ, Rolnick SJ, Harris EL, Barlow WE, Reisch LM, Fletcher SW, Elmore JG. Screening clinical breast examination: how often does it miss lethal breast cancer? J Natl Cancer Inst Monogr 2005;(35):67-71.
	Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 2005;(35):88-95.
	Nekhlyudov L, Bower M, Herrinton LJ,* Altschuler A, Greene SM, Rolnick S, Elmore JG, Harris EL, Liu A, Emmons KM, Fletcher SW, Geiger AM. Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005;(35):55-60.
	Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM. Building a research consortium of large health systems: The Cancer Research Network. J Natl Cancer Inst Monogr 2005;(35):3-11.
	West CN, Geiger AM, Greene SM, Harris EL, Liu IL, Barton MB, Elmore JG, Rolnick S, Nekhlyudov L, Altschuler A, Herrinton LJ, Fletcher SW, Emmons KM. Race and ethnicity: comparing medical records to self-reports. J Natl Cancer Inst Monogr 2005;(35):72-4.
	Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, RolnickSJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006 Mar 20;24(9):1350-6.
	Iribarren C, Herrinton LJ, Darbinian JA, Tamarkin L, Malinowski D, Vogelman JH, Orentreich N, Baer D. Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race? Vasc Med. 2006 Feb;11(1):13-20.
	Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 2006;24:1350-6.